Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Glaukos Corporation clinical trials
The registry lists 67 studies whose lead sponsor is Glaukos Corporation. 14 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 30, 2026.
Keep track of what changes. Save the Glaukos Corporation studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Glaukos Corporation.
- Glaukos Corporation67 studiesSame company
Something wrong?
Focus areas
Conditions Glaukos Corporation leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 67. Browse all 67 →
- iDose TR Administration in an Office-Based Surgery SettingRecruitingNCT07816692
- Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantRecruitingNCT07075718Phase 2
- Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for KeratoconusRecruitingNCT07629557Phase 4
- Travoprost Intraocular Implant + iStent InfiniteRecruitingNCT06066645Phase 4
- Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantRecruitingNCT07495852Phase 3
- Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcgRecruitingNCT07400926
- Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex BlepharitisRecruitingNCT07400965Phase 2
- Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With KeratoconusRecruitingNCT07400952Phase 2
- Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AloneRecruitingNCT06848946Phase 4
- A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDRecruitingNCT05966493Phase 2
- Safety and Efficacy of Corneal Cross-linking in Subjects With KeratoconusRecruitingNCT05314738Phase 1/2
- Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive SurgeryRecruitingNCT03319082
- Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular HypertensionRecruitingNCT06152861Phase 2
- Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle GlaucomaRecruitingNCT06057051Not applicable
- NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular InjuriesTerminatedNCT04081103Phase 2
- Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%CompletedNCT03519386Phase 3
- Clinical Study Comparing Two Models of a Travoprost Intraocular ImplantCompletedNCT03868124Phase 3
- Performance of the Travoprost Intraocular ImplantCompletedNCT06582732Phase 2
- Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. CompetitorActive, not recruitingNCT05127551Not applicable
- Travoprost Intraocular Implant in Conjunction With Cataract SurgeryActive, not recruitingNCT06061718Phase 3
- iStent Inject New Enrollment Post-Approval StudyActive, not recruitingNCT04624698Not applicable
- Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive KeratoconusCompletedNCT03442751Phase 3
- Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic SolutionCompletedNCT02754596Phase 2
- Study of Exchange of Travoprost Intraocular ImplantCompletedNCT04615403Phase 2
- Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of PresbyopiaCompletedNCT05124275Phase 2
- Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye DiseaseCompletedNCT05119920Phase 2
- Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser TrabeculoplastyTerminatedNCT02327312Not applicable
- Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One iStent and One iStent SupraCompletedNCT03255785Not applicable
- iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive MedicationsTerminatedNCT03478293Not applicable
- A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent SupraTerminatedNCT03255798Not applicable
- Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or TravoprostCompletedNCT01444040Phase 4
- Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive MedicationCompletedNCT02868190Phase 4
- A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal StentCompletedNCT01252914Phase 4
- Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass StentsCompletedNCT01456390Not applicable
- Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive AgentsCompletedNCT02873806Phase 4
- Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStentsCompletedNCT01252888Phase 4
- Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract SurgeryCompletedNCT01455467Not applicable
- Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma SubjectsCompletedNCT01252849Not applicable
- Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser TrabeculoplastyCompletedNCT01444105Not applicable
- One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma SubjectsCompletedNCT01517477Not applicable
- Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract SurgeryCompletedNCT01461291Not applicable
- Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract SurgeryCompletedNCT01461278Not applicable
- Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract SurgeryStatus unknownNCT01841450Not applicable
- iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval StudyStatus unknownNCT04624685
- Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With KeratoconusCompletedNCT01643226Phase 3
- Feasibility Study of the Vedera KXS for Treatment of KeratoconusCompletedNCT01069848Not applicable
- Clinical Evaluation of the Vedera KXS for the Treatment of Spherical MyopiaCompletedNCT00925041Not applicable
- Corneal Collagen Cross-linking for Progressive KeratoconusCompletedNCT00647699Phase 3
- Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic AstigmatismTerminatedNCT01893359Phase 1/2
- Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive SurgeryWithdrawnNCT01643252Phase 3